LuPSMA moves UpFront | first RCT data with Arun Azad and Michael Hofman

ANZSNM ArtNet Talk by Professor Michael Hofman #ProsTICПодробнее

Prostic24 - Multi-discplinary meeting / Tumor Board - Theranostics and Lutetium-PSMAПодробнее

UpFrontPSMA trial: 177Lu-PSMA-617 and docetaxel in mHNPCПодробнее

First Results of TheraP trialПодробнее

ProsTIC24 - Arun Azad: Trial Update: CombinationsПодробнее

TheraP Study: Lu-PSMA vs. cabazitaxel #ASCO20 #ANZUPПодробнее

177Lu-PSMA-617 for the early treatment of prostate cancerПодробнее

Professor Michael Hofman: prostate cancer imaging and treatmentПодробнее

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PCПодробнее

PCF - ProsTIC - ANZUP Global Knowledge Exchange Webinar on the TheraP studyПодробнее

Frontline Consolidation in B-ALL: Expert Insights on the Role of BlinatumomabПодробнее

FLAME trialПодробнее

Phase I/II trial of AdAPT-001, an oncolytic virus, and a checkpoint inhibitor in solid tumorsПодробнее

Advances in theranostics for prostate cancerПодробнее

Initial results from Phase I/II Study of ARV-766 in mCRPCПодробнее

ECLIPSE - A Randomized Phase 3 Trial for 177-Lu-PSMA-I&T in patients with mCRPCПодробнее

Prof Michael Hofman talks to Nine News about the TherpaP trialПодробнее

LuPSMA: The Newest Treatment Class for Advanced Prostate CancerПодробнее

Peter Mac's Arun Azad talks new prostate cancer treatmentПодробнее